Thompson MidCap Fund NBIX Holdings History
Thompson MidCap Fund's Neurocrine Biosciences Inc Holding Summary
As of 2025-02-28, THOMPSON IM FUNDS INC held 9,755.00 shares of Neurocrine Biosciences Inc(NBIX), totaling $1.16 Mil. This investment constitutes 2.11% of their stock portfolio, and THOMPSON IM FUNDS INC now holds 0.01% of the outstanding Neurocrine Biosciences Inc(NBIX) stock.
The initial trade took place in 2022Q1. And since then Thompson MidCap Fund has made 7 purchases of NBIX, at an average price of $94.82, for a total of 12,055.00 shares. In addition, there have been 2 sales at an average price of $104.22 for 2,300.00 shares. Based on historical transaction data and NBIX's current price of $131.24, Thompson MidCap Fund's estimated gain on his NBIX holdings is $376,877.50, reflecting a 32.97% gain to date.
Thompson MidCap Fund NBIX ($131.24) Holding Chart
Thompson MidCap Fund NBIX ($131.24) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
